Skip to main content
. 2020 May 27;2020:8213082. doi: 10.1155/2020/8213082

Table 3.

The mean score of SF-36, SF-36PH, and SF-36MH. Intention-to-treat population.

Group Mean baseline (±s.d.) P Mean week 2 (±s.d.) Mean CBTW2 (±s.d.) Mean week 4 (±s.d.) Mean C2WAT (±s.d.)
SF-36 Control (n = 29) 76.3 (5.5) 0.95 85.8 (5.6) 9.5 (6.1) 79.9 (7) 5.9 (3.7)
Intervention (n = 31) 76.8 (6) 92.3 (4.8) 15.6 (6.8) 90.3 (5.2) 2 (2.9)

SF-36PH Control (n = 29) 74.5 (6.7) 0.47 84.9 (6.2) 10.7 (6.4) 78.8 (7.4) 6 (4.1)
Intervention (n = 31) 75.7 (8) 92.1 (5) 16.4 (8.9) 90.5 (6) 1.7 (2)

SF-36MH Control (n = 29) 76.2 (7) 0.90 86.6 (5.9) 11.1 (6.2) 80.8 (6.8) 4.7 (4.5)
Intervention (n = 31) 76.4 (6.9) 92.4 (5.6) 16 (7.2) 91.4 (4.7) 1.9 (2.5)

P: P value; SF-36: 36-Item Short-Form Health Survey; SF-36PH: 36-Item Short-Form Health Survey physical health; SF-36MH: 36-Item Short-Form Health Survey mental health; mean CBTW2: mean change baseline to week 2; mean C2WAT: mean change 2 week after treatment; intervention: herbal medicine; control: hyoscine. P < 0.001, intervention vs. control.